Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma
- PMID: 22993605
- PMCID: PMC3445952
- DOI: 10.3892/etm.2010.132
Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma
Abstract
The mechanism responsible for the development of hepatocellular carcinoma (HCC) in the setting of oxidative stress has yet to be clearly defined. We studied the role of oxidative stress in hepatocarcinogenesis in subjects without underlying chronic viral hepatitis. The subjects were 24 patients negative for serum hepatitis B surface antigen and hepatitis C antibody tests, who underwent hepatic resection for HCC (Group N). Subjects were excluded if diagnosed with liver disease predisposing to HCC. Immunohistochemical staining for oxidative stress-related markers was performed on non-cancerous liver regions. Resected liver tissues adjacent to HCC from 24 patients with chronic hepatitis B (Group B) and 21 patients with chronic hepatitis C (Group C) were also examined. The percentage of 8-hydroxydeoxyguanosine-positive hepatocytes in Group N was significantly lower than that in Group B and that in the combined population of Groups B and C. The percentage of the area positive for 4-hydroxynonenal in Group N was significantly higher than that in Groups B or C. Meanwhile, the percentage of the area positive for manganese superoxide dismutase in Group N was not different from that in Groups B and C. In conclusion, the mechanism of hepatocarcinogenesis through oxidative stress for patients without known liver disease predisposing to HCC may differ from that for patients with chronic viral hepatitis.
Figures






Similar articles
-
Molecular mechanism of hepatocarcinogenesis.J Gastroenterol Hepatol. 1997 Oct;12(9-10):S309-13. doi: 10.1111/j.1440-1746.1997.tb00514.x. J Gastroenterol Hepatol. 1997. PMID: 9407351 Review.
-
Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.Ann Surg Oncol. 2007 Mar;14(3):1182-90. doi: 10.1245/s10434-006-9049-1. Ann Surg Oncol. 2007. PMID: 17195915
-
Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.Clin Gastroenterol Hepatol. 2020 Feb;18(2):449-456. doi: 10.1016/j.cgh.2019.06.029. Epub 2019 Jun 25. Clin Gastroenterol Hepatol. 2020. PMID: 31252193
-
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.Ann Surg Oncol. 2000 Dec;7(10):764-70. doi: 10.1007/s10434-000-0764-8. Ann Surg Oncol. 2000. PMID: 11129425
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
References
-
- Wong F, Choi T. Primary liver cancer. Asian experience. In: Blumgart LH, editor. Surgery of Liver and Biliary Tract. Churchill-Livingstone; London: 1988. pp. 1135–1151.
-
- The Research Group for Population-based Cancer Resistration in Japan Cancer incidence and incidence rates in Japan in 1995: estimates based on data from nine population-based cancer registries. Jpn J Clin Oncol. 2000;30:318–321. - PubMed
-
- Tanaka H, Tsukuma H. Hepatitis C virus. In: Newton R, Beral V, Weiss RA, Tooze J, editors. Cancer Surveys: Infections and Human Cancer. Cold Spring Harbor Laboratory; New York: 1999. pp. 213–235.
-
- Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 1991;14:969–974. - PubMed
-
- Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12:671–675. - PubMed
LinkOut - more resources
Full Text Sources